These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
839 related articles for article (PubMed ID: 12097277)
1. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277 [TBL] [Abstract][Full Text] [Related]
2. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
3. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536 [TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917 [TBL] [Abstract][Full Text] [Related]
6. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288 [TBL] [Abstract][Full Text] [Related]
7. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822 [TBL] [Abstract][Full Text] [Related]
8. Frequent hypermethylation of the RASSF1A gene in prostate cancer. Liu L; Yoon JH; Dammann R; Pfeifer GP Oncogene; 2002 Oct; 21(44):6835-40. PubMed ID: 12360410 [TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
10. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
11. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Dammann R; Yang G; Pfeifer GP Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521 [TBL] [Abstract][Full Text] [Related]
14. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729 [TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168 [TBL] [Abstract][Full Text] [Related]
16. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Dammann R; Takahashi T; Pfeifer GP Oncogene; 2001 Jun; 20(27):3563-7. PubMed ID: 11429703 [TBL] [Abstract][Full Text] [Related]
17. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579 [TBL] [Abstract][Full Text] [Related]
19. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma. Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078 [TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]